2022
DOI: 10.1128/mbio.03287-21
|View full text |Cite
|
Sign up to set email alerts
|

Novel Function of Avian p53 in Binding to ALV-J LTR Contributes to Its Antiviral Roles

Abstract: Rous sarcoma virus (RSV)/ALV was the first retrovirus to be discovered, which was really the first hint that cancer, or a tumor, could be transmitted by a virus. The specific mechanisms that regulate ALV replication during infection remain poorly understood.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Although some studies suggest that p53 inhibits viral replication by affecting innate immune factors, the potential association between chp53 and those innate immune factors remains unclear ( 76 , 130 ). However, a recent study indicates that p53 recruits the histone deacetylase 1 and 2 (HDAC1/2) complex to the ALV-J long terminal repeat (LTR) region which regulates viral replication to switch off gene expression ( 131 , 132 ), suggesting that p53 inhibits ALV replication not only by activating innate immune response but also by inhibiting ALV-J LTR activity. Current information is still insufficient to determine the proportion of chp53 effect on suppression of ALV-J replication via innate immunity or regulating LTR of ALV.…”
Section: Innate Immune Evasion By Avian Leukosis Virus (Alv)mentioning
confidence: 99%
“…Although some studies suggest that p53 inhibits viral replication by affecting innate immune factors, the potential association between chp53 and those innate immune factors remains unclear ( 76 , 130 ). However, a recent study indicates that p53 recruits the histone deacetylase 1 and 2 (HDAC1/2) complex to the ALV-J long terminal repeat (LTR) region which regulates viral replication to switch off gene expression ( 131 , 132 ), suggesting that p53 inhibits ALV replication not only by activating innate immune response but also by inhibiting ALV-J LTR activity. Current information is still insufficient to determine the proportion of chp53 effect on suppression of ALV-J replication via innate immunity or regulating LTR of ALV.…”
Section: Innate Immune Evasion By Avian Leukosis Virus (Alv)mentioning
confidence: 99%
“…In addition to the signalling pathway, several host proteins have been confirmed to inhibit viral replication. The oncogene p53 transcription factor recruits histone deacetylase 1 and 2 (HDAC1/2) to shut off the promoter activity of ALV integration region ( 75 ). Chicken tripartite motif-containing 62 (TRIM62) inhibits ALV-J replication through the SPRY structural domain ( 76 ), and chicken TRIM25, a member of the same tripartite motif (TRIM) family, also inhibits ALV-A replication by regulating MDA5 -mediated type I IFN response ( 77 ).…”
Section: Cellular Factors Affecting Alv Replicationmentioning
confidence: 99%
“…Globally, avian leukosis viruses (ALVs) cause severe economic losses to the poultry industry because of their infectiousness and retroviral properties [ 1 ]. Based on the host range [ 2 ], antibody neutralization and receptor interference studies [ 3 ], ALVs that infect chickens can be divided into subgroups A, B, C, D, E, J and K. Among these subgroups, subgroup J (ALV-J), which was first isolated from meat-type breeder chickens in 1988 [ 4 ], is the most prevalent in chickens [ 5 7 ]. Following the initiation of a nationwide eradication program (NEP) in 2008, the infection rate of exogenous ALVs in China decreased significantly [ 8 ].…”
Section: Introductionmentioning
confidence: 99%